Search global stocks & ETFs...Ctrl K
Learn Mode
Abbott LaboratoriesABT
$88.50
-$2.12 (-2.339%)
$88.54
$0.04 (0.046%)
ABT
Stock Profile
07-15
Recommended Metric
Score Card
Explore Scores Tab
3.85
Good
Valuation Score
Key Score
5.00
Very Good
Management
3.00
Average
Growth
5.00
Very Good
Profitability
4.00
Good
Fin. Health
1.00
Very Bad
Dividends
5.00
Very Good
Analyst
3.00
Average
Insider Transactions
Explore Insider Tab ›Buy Transactions
Sell Transactions
Peers
Select stocks to compare
Price Targets & Ratings
View Analysis
1-year price targets, ending May 11, 2027
Current
$88.50
Baseline
High
$150.15
▲
69.66%
Avg
$122.05
▲
37.91%
Low
$92.92
▲
4.99%
Analyst Ratings based on 34 Analysts
Strong Buy
1029%
Buy
1441%
Hold
1029%
Sell
000%
Strong Sell
000%
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.Read More
Stock News
View All Updates
News100%Bullish
The Hidden Winners Inside SCHD - June 2026 Breakdown
7hSeekingAlpha
Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)
11hYahoo
MiniMed's Smallest App-Controlled Insulin Pump is Now Available in the U.S.
19hYahoo
Abbott's CGM Growth Story Stays Intact Despite Q1 Moderation
1dYahoo
Is STERIS Stock Underperforming the Dow?
2dYahoo
The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels
2dBenzinga
Texas Rep. Julie Johnson Sold Up to $30K Worth of Abbott Laboratories Stock
2dBenzinga
How Investors May Respond To Abbott (ABT) Dividend And CE Mark For Dual Glucose‑Ketone Sensor
3dYahoo
Abbott Laboratories (ABT): One of the Best Bargain Stocks to Buy in June
3dYahoo
Is Abbott (ABT) the Best Longevity Stock to Buy Now?
4dYahoo
Abbott (ABT) Stock Declines While Market Improves: Some Information for Investors
5dYahoo
Abbott declares 410th consecutive quarterly dividend
5dYahoo
Abbott Laboratories Remains Structurally Undervalued
6dSeekingAlpha
Elfun Trusts Exits Abbott Laboratories, Impacting Portfolio by -1.97%
6dYahoo
Abbott Labs is heavily oversold, says Powers Advisory Group's Matt Powers
6dCNBC
Star51 Capital Announces First Close of Medtech Venture Fund
6dYahoo
This is Why Abbott Laboratories (ABT) is One of the Best Deep Value Stock to Invest In
1wYahoo
Abbott Diabetes And Cancer Milestones Contrast With Prolonged Share Price Weakness
1wYahoo
Abbott (ABT) Dips More Than Broader Market: What You Should Know
1wYahoo
Mounting Evidence Backs Abbott's Cancer Diagnostics Growth Story
1wYahoo
Is Medtronic Stock a Buy at 14x Forward Earnings?
1wYahoo
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
1wYahoo
Abbott Laboratories: A Better Than 5 Years Ago - But Still Not A Buy
1wSeekingAlpha
New Investors: 3 Rock-Solid Stocks to Build Your Portfolio Around
1wYahoo
Abbott (ABT) Secures CE Mark for World’s First Dual Glucose‑Ketone Sensing Technology for Diabetes
1wYahoo
Chemiluminescence Immunoassay Market by Product, Technology, Sample Type, Application, End User - Global Forecast to 2031
1wYahoo
When Investors Finally Get Sick of AI Stocks, This Medical Devices ETF Could Be a Long-Term Winner
1wYahoo
143 investors said no to his wearable idea, he says—now Whoop is worth $10.1 billion
1wCNBC
Is It Time To Revisit Abbott Laboratories (ABT) After This Year’s Share Price Slump?
1wYahoo
Goldman Sachs Maintains Buy Rating on Abbott Laboratories (ABT) Stock
1wYahoo
New research shows even stronger health outcomes for participants in a 'Food is Medicine' program when paired with support from community health workers
1wYahoo
Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500?
1wYahoo
Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option
1wYahoo
Baron Discovery Fund Q1 2026: Who Moved The Needle
1wSeekingAlpha
New Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis
1wYahoo
A Grandma Bought PediaSure To Help Her Grandson Grow — Now, Abbott Is In Federal Court
1wBenzinga
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)?
1wYahoo
Cardiac Monitoring & Rhythm Management Devices Market by Type, Application, End User - Global Forecast to 2031
1wYahoo
Abbott Addresses a Major Diabetes Care Gap With Tech Innovation
1wYahoo
Jim Cramer Says “No One Disputes the Science and Commercial Smarts of Abbott”
1wYahoo
Assessing Abbott Laboratories (ABT) Valuation After New Diabetes Sensor And Cancer Screening Tailwinds
2wYahoo
Medtronic Stock Is Defying a Market Selloff After Earnings. Here’s Why.
2wYahoo
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
2wYahoo
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
2wYahoo
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
2wYahoo
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
2wYahoo
MiniMed Announces Expanded Agreement With Abbott To Collaborate On Commercializing Dual Glucose-Ketone Sensors Designed To Integrate Exclusively With MiniMed Smart Dosing Systems
2wBenzinga
How A Steady Valuation Is Shaping The Evolving Abbott Laboratories (ABT) Investment Story
2wYahoo
Tracking Jeremy Grantham's GMO Capital Portfolio - Q1 2026 Update
2wSeekingAlpha
Why Investors Are Cautious on Abbott Laboratories (ABT)?
2wYahoo